Patients with COPD are often affected by sarcopenia, but the underlying mechanisms for the development are poorly understood. New research looks into the causes and potential therapies
NIV has become an invaluable tool for patients with COPD, but the associated financial and logistical challenges created the need for a new ambulatory NIV titration program
Physician experience refines patient selection criteria for endoscopic lung volume reduction
Careful history and clinical observation are still valuable tools
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study is first to link alcohol with adverse outcomes and increased hospitalization
Continuity of care to the fullest
Certain precautions must be taken to reduce aerosolization during treatments
Benefits could extend to patients with COPD
Analysis shows early benefits
Only for patients at high risk of severe exacerbations